Yangxian Xu

753 citations
15 papers · 365 indexed · h-index 9
Topics
Cancer-related molecular mechanisms research (6 papers)Circular RNAs in diseases (4 papers)MicroRNA in disease regulation (4 papers)
Journals
SHILAP Revista de lepidopterologíaScientific ReportsJournal of Ethnopharmacology
Partner nations
ChinaUnited StatesCanada

In The Last Decade

Yangxian Xu

15 papers receiving 364 citations

Peers

Yangxian Xu
Comparison fields: 5 of 66
  • Molecular Biology 295
  • Cancer Research 199
  • Oncology 44
  • Pathology and Forensic Medicine 31
  • Pulmonary and Respiratory Medicine 30
Replace Deqin Wu with:
Deqin Wu China
Xiaochun Xia China
Zeqiang Ren China
Siwei Liu China
Bang Hu China
Weiqian Li China
Yongfei Dong China
Mingzhe Zhu China
Zeng Chang-qian China
Emma Martell Canada
Yangxian Xu relative to Deqin Wu China Deqin Wu's profile →
Citations per field
00.5×3.5×
Deqin Wu · 1×
Citations per year

Countries citing papers authored by Yangxian Xu

Since Specialization
Citations

This map shows the geographic impact of Yangxian Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yangxian Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yangxian Xu more than expected).

Fields of papers citing papers by Yangxian Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yangxian Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yangxian Xu. The network helps show where Yangxian Xu may publish in the future.

Co-authorship network of co-authors of Yangxian Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Yangxian Xu. A scholar is included among the top collaborators of Yangxian Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yangxian Xu. Yangxian Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
#WorkIndexed citations
1 3
2 1
3 1
4 4
5 8
6 72
7 3
8 7
9 17
10 16
11 103
12 28
13 14
14 36
15 52

About Yangxian Xu

Yangxian Xu is a scholar working on Cancer Research, Complementary and alternative medicine and Pharmacology, having authored 15 papers that have together received 365 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (6 papers), Circular RNAs in diseases (4 papers) and MicroRNA in disease regulation (4 papers). The work is most often cited by research in Cancer Research (199 citations), Biological Psychiatry (12 citations) and Molecular Biology (295 citations). Yangxian Xu has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Guang Ji, Hanchen Xu, Wenjun Zhou, Yujing Liu, Yang Liu, Chunyan Wang, Yanqi Dang, Mingzhe Zhu, Haiyan Song and Aiguang Zhao. Their work appears in journals such as SHILAP Revista de lepidopterología, Scientific Reports and Journal of Ethnopharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026